WAVE Life Sciences Ltd (WVE)
6.26
+0.36
(+6.10%)
USD |
NASDAQ |
May 17, 16:00
6.26
0.00 (0.00%)
After-Hours: 18:48
WAVE Life Sciences Cash from Financing (TTM): 111.99M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 111.99M |
| December 31, 2023 | 132.53M |
| September 30, 2023 | 38.63M |
| June 30, 2023 | 36.97M |
| March 31, 2023 | 100.92M |
| December 31, 2022 | 67.19M |
| September 30, 2022 | 100.93M |
| June 30, 2022 | 109.26M |
| March 31, 2022 | 48.50M |
| December 31, 2021 | 55.83M |
| September 30, 2021 | 22.05M |
| June 30, 2021 | 156.23M |
| March 31, 2021 | 162.56M |
| December 31, 2020 | 154.54M |
| September 30, 2020 | 155.28M |
| June 30, 2020 | 13.01M |
| March 31, 2020 | 1.467M |
| Date | Value |
|---|---|
| December 31, 2019 | 164.40M |
| September 30, 2019 | 164.29M |
| June 30, 2019 | 165.39M |
| March 31, 2019 | 227.10M |
| December 31, 2018 | 65.09M |
| September 30, 2018 | 65.04M |
| June 30, 2018 | 63.74M |
| March 31, 2018 | 95.72M |
| December 31, 2017 | 94.37M |
| September 30, 2017 | 93.80M |
| June 30, 2017 | 93.92M |
| March 31, 2017 | 29.33M |
| December 31, 2016 | 29.12M |
| September 30, 2016 | 131.84M |
| June 30, 2016 | 192.87M |
| March 31, 2016 | 163.95M |
| December 31, 2015 | 175.59M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
1.467M
Minimum
Mar 2020
165.39M
Maximum
Jun 2019
98.10M
Average
105.09M
Median